Lucijanić, M., Galušić, D., Sorić, E., Sedinić, M., Ćubela, M., Huzjan Korunić, R. ... Kušec, R. (2021). Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology, 100. (4), 1105-1106. doi: 10.1007/s00277-020-04243-8
Lucijanić, Marko, et al. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology, vol. 100, no. 4, 2021, pp. 1105-1106. https://doi.org/10.1007/s00277-020-04243-8
Lucijanić, Marko, Davor Galušić, Ena Sorić, Martina Sedinić, Marta Ćubela, Renata Huzjan Korunić, Vlatko Pejša and Rajko Kušec. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology 100, no. 4 (2021): 1105-1106. https://doi.org/10.1007/s00277-020-04243-8
Lucijanić, M., et al. (2021) 'Ruxolitinib treatment improves muscle mass in patients with myelofibrosis', Annals of Hematology, 100(4), pp. 1105-1106. doi: 10.1007/s00277-020-04243-8
Lucijanić M, Galušić D, Sorić E, Sedinić M, Ćubela M, Huzjan Korunić R, and sur.. Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology [Internet]. 2021 April [cited 2024 April 19];100(4):1105-1106. doi: 10.1007/s00277-020-04243-8
M. Lucijanić, et al., "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis", Annals of Hematology, vol. 100, no. 4, pp. 1105-1106, April 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:268065. [Accessed: 19 April 2024]
